✦ LIBER ✦

Poor metabolisers of nicotine and CYP2D6 polymorphism

✍ Scribed by S. Cholerton; A. Arpanahi; N. McCracken; C. Boustead; H. Taber; E. Johnstone; J. Leathart; A.K. Daly; J.R. Idle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MDMA (ecstasy) pharmacokinetics in a CYP

✍ Rafael de la Torre; Magí Farré; Brian Ó Mathúna; Pere N. Roset; Neus Pizarro; Mi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 192 KB

CYP2D6 poor metaboliser genotype and ora

✍ Stephen F. Worrall 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 269 KB

CYP2A6 polymorphism, nicotine, and envir

✍ Jeffrey R Idle 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 60 KB

Identification of inhibitors of the nico

✍ Rahnasto, M; Wittekindt, C; Juvonen, R O; Turpeinen, M; Petsalo, A; Pelkonen, O; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 256 KB

Genetic Polymorphism in Cytochrome P450

✍ Neafsey, Patricia; Ginsberg, Gary; Hattis, Dale; Sonawane, Babasaheb 📂 Article 📅 2009 🏛 Taylor and Francis Group 🌐 English ⚖ 396 KB

DNA haplotype dependency of debrisoquine

✍ C. Mura; S. Panserat; M. Vincent-Viry; M. M. Galteau; E. Jacqz-Aigrain; R. Krish 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 610 KB